Abstract
We determined social and behavioral factors associated with virologic non-suppression among pregnant women receiving Option B+ antiretroviral treatment (ART). Baseline data was used from women in Mobile WAChX trial from 6 public maternal child health (MCH) clinics in Kenya. Virologic non-suppression was defined as HIV viral load (VL) ≥1000 copies/ml. Antiretroviral resistance testing was performed using oligonucleotide ligation (OLA) assay. ART adherence information, motivation and behavioral skills were assessed using Lifewindows IMB tool, depression using PHQ-9, and food insecurity with the Household Food Insecurity Access Scale. Correlates of virologic non-suppression were assessed using Poisson regression. Among 470 pregnant women on ART ≥4 months, 57 (12.1%) had virologic non-suppression, of whom 65% had HIV drug resistance mutations. In univariate analyses, risk of virologic non-suppression was associated with moderate-to-severe food insecurity (RR 1.80 [95% CI 1.06–3.05]), and varied significantly by clinic site (range 2%-22%, p <0.001). In contrast, disclosure (RR 0.36 [95% CI 0.17–0.78]) and having higher adherence skills (RR 0.70 [95% CI 0.58–0.85]) were associated with lower risk of virologic non-suppression. In multivariate analysis adjusting for clinic site, disclosure, depression symptoms, adherence behavior skills and food insecurity, disclosure and food insecurity remained associated with virologic non-suppression. Age, side-effects, social support, physical or emotional abuse, and distance were not associated with virologic non-suppression. Prevalence of virologic non-suppression among pregnant women on ART was appreciable and associated with food insecurity, disclosure and frequent drug resistance. HIV VL and resistance monitoring, and tailored counseling addressing food security and disclosure, may improve virologic suppression in pregnancy.
Funder
Foundation for the National Institutes of Health
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Global AIDS Update 2018. MILES TO GO. Closing Gaps, Breaking Barriers, Righting injustices. UNAIDS. https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf
2. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B + era: 12-month cohort study in urban South Africa and rural Uganda;LT Matthews;J Int AIDS Soc,2020
3. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi’s Option B + Program;AD Haas;Clin Infect Dis,2016
4. Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B + for PMTCT;P Machnowska;PLoS One,2017
5. Viral suppression and HIV drug resistance at 6 months among women in Malawi’s option B+ program: Results from the PURE Malawi study;M Hosseinipour;J Acquir Immune Defic Syndr,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献